10,629 reports of this reaction
4.1% of all MYCOPHENOLATE MOFETIL HYDROCHLORIDE reports
#2 most reported adverse reaction
DRUG INEFFECTIVE is the #2 most commonly reported adverse reaction for MYCOPHENOLATE MOFETIL HYDROCHLORIDE, manufactured by Genentech, Inc.. There are 10,629 FDA adverse event reports linking MYCOPHENOLATE MOFETIL HYDROCHLORIDE to DRUG INEFFECTIVE. This represents approximately 4.1% of all 257,534 adverse event reports for this drug.
MYCOPHENOLATE MOFETIL HYDROCHLORIDE has an overall safety score of 92 out of 100. Patients taking MYCOPHENOLATE MOFETIL HYDROCHLORIDE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among MYCOPHENOLATE MOFETIL HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for MYCOPHENOLATE MOFETIL HYDROCHLORIDE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 10,629 FDA reports for MYCOPHENOLATE MOFETIL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 4.1% of all adverse event reports for MYCOPHENOLATE MOFETIL HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking MYCOPHENOLATE MOFETIL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.